(Q35228272)

7 August 2017

1 reference

title

Prospects for selective cyclic nucleotide phosphodiesterase inhibitors in the treatment of bronchial asthma (English)

1 reference

7 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

4 December 2023

author name string

M. A. Giembycz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316796

12 September 2022

G. Dent

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1316796

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1316796

12 September 2022

publication date

1 March 1992

1 reference

full work available at URL

7 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2222.1992.tb03095.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2222.1992.tb03095.x

4 December 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Clinical & Experimental Allergy

4 December 2023

published in

1 reference

7 August 2017

volume

22

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

337-344

1 reference

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

The presence of five cyclic nucleotide phosphodiesterase isoenzyme activities in bovine tracheal smooth muscle and the functional effects of selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Biochemical and electrical aspects of the tracheal relaxant action of AH 21-132

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Lack of effect of zaprinast on methacholine-induced contraction and inositol 1,4,5-trisphosphate accumulation in bovine tracheal smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

The effect of zaprinast (M&B 22,948, an orally absorbed mast cell stabilizer) on exercise-induced asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan-stimulated respiratory burst by 'type IV'-selective PDE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Characterization of guinea-pig eosinophil phosphodiesterase activity. Assessment of its involvement in regulating superoxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2,2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Cyclic-GMP-dependent refilling of calcium stores in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Eosinophil accumulation in pulmonary airways of guinea-pigs induced by exposure to an aerosol of platelet-activating factor: effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2222.1992.TB03095.X

Multiple isozymes of cyclic nucleotide phosphodiesterase

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle

4 December 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Selective inhibition of a high affinity type IV cyclic AMP phosphodiesterase in bovine trachealis by AH 21-132. Relevance to the spasmolytic and anti-spasmogenic actions of AH 21-132 in the intact tissue

4 December 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

The isoenzyme selectivity of AH 21-132 as an inhibitor of cyclic nucleotide phosphodiesterase activity

4 December 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Inhibition of the low km cyclic AMP phosphodiesterase in intact canine trachealis by SK&F 94836: mechanical and biochemical responses

4 December 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Reduction in pulmonary hypertension and in airway resistances by enoximone (MDL 17,043) in decompensated COPD.

4 December 2023

20

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst

4 December 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Influence of cyclic nucleotides and a phosphodiesterase inhibitor on in vitro human blood neutrophil chemotaxis

4 December 2023

34

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function.

4 December 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

High pressure liquid chromatography of cyclic nucleotide phosphodiesterase from purified human T-lymphocytes

4 December 2023

44

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents.

4 December 2023

47

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Human alveolar macrophage activation: inhibition by forskolin but not beta-adrenoceptor stimulation or phosphodiesterase inhibition

4 December 2023

50

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells

4 December 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

Zardaverine: a cyclic AMP specific PDE III/IV inhibitor

4 December 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1365-2222.1992.TB03095.X

4 December 2023

Identifiers

1 reference

7 August 2017

1 reference